Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2007, p. 3634-3641, Vol. 51, No. 10
0066-4804/07/$08.00+0 doi:10.1128/AAC.00380-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Biological Science Laboratories, Kao Corporation, Tochigi, Japan,1 Materials Development Research Laboratories, Kao Corporation, Wakayama, Japan,2 Safety and Microbial Control Research Center, Kao Corporation, Tochigi, Japan,3 Health Care Products Research Laboratories No. 1, Kao Corporation, Tokyo, Japan,4 Department of Clinical Pathophysiology, Tokyo Dental College, Chiba, Japan,5 Department of Epidemiology and Public Health, Tokyo Dental College, Chiba, Japan6
Received 21 March 2007/ Returned for modification 19 April 2007/ Accepted 15 July 2007
|
|
|---|
|
|
|---|
98% [wt/wt] hydroxyapatite [HA]) and promotes the adhesion of S. mutans by specific (2, 17) and nonspecific (4) mechanisms. Saliva contains a multitude of proteins that contribute to oral microbial ecology and biofilm formation (6, 16, 32). A variety of salivary proteins have been shown to modulate bacterial adhesion onto HA surfaces in vitro. Adsorption of specific salivary proteins, such as acidic proline-rich proteins (8) and agglutinin (3), promotes the adhesion of S. mutans onto HA surfaces by providing ligands for bacterial attachment. Many studies thus far have suggested that an initial bacterial adhesion promoted by salivary protein adsorption onto the enamel surface contributes to facilitate dental biofilm development.
Recently, we reported the clinical relevance of saliva-promoted S. mutans adhesion in both de novo dental biofilm development and caries experience (29). Dental biofilm formation after thorough teeth cleaning was positively correlated with both salivary glycoprotein content and S. mutans adhesion onto saliva-coated HA surfaces. A higher glycoprotein content forms an "adhesive" conditioning film (acquired pellicle) that promotes a higher rate of bacterial attachment onto HA surfaces in vitro (28).
In contrast to salivary glycoprotein, some small salivary proteins, statherin (26) and histatin 1 (20), have an inhibitory effect on saliva-mediated S. mutans adhesion in vitro (28). These non-S. mutans-binding phosphoproteins reduce S. mutans adhesion by competitively inhibiting the adsorption of S. mutans-binding salivary glycoproteins to HA surfaces. If competitive inhibition serves as a general mechanism for salivary protein adhesion to enamel surfaces, acquired enamel pellicle and dental biofilm formations may be controlled for prevention and therapy by the development of novel biomimetic compounds, e.g., statherin or histatin 1-like substances.
The aim of the present study was to develop antiadherence compounds for preventing de novo dental biofilm development. To design statherin or histatin 1-like compounds, we considered the following two factors. (i) Our previous study showed that the phosphate and carboxyl groups in the N-terminal domain of statherin and histatin 1, which are capable of binding to HA surfaces through charge interactions, were essential for their inhibitory effects on bacterial adhesion, as well as noncharged or weakly charged amino acid domains (28). (ii) The studies thus far have proved that a noncharged hydrophilic surface, which may result from treatment with, for example, polyethylene glycol (PEG) derivatives, prevent bacterial adhesion effectively (12, 21, 22). Taking these together, we investigated the possibility of HA surface pretreatment with phosphorylated PEG derivatives for preventing saliva-promoted S. mutans adhesion in vitro and de novo dental biofilm formation in vivo.
|
|
|---|
![]() View larger version (10K): [in a new window] |
FIG. 1. Structure of phosphorylated PEG derivatives synthesized in the present study. l, m, and n, molar numbers of methacryloyloxyalkyl phosphate, PEG, and methacrylate groups, respectively, in the polymer. r, Number of methyl groups (linker length) between methacryloyl and phosphate groups; q, number of ethoxy groups of PEG.
|
|
View this table: [in a new window] |
TABLE 1. Effects of pretreatment of sintered HA plates with polymers on saliva-promoted S. mutans adhesion
|
In vitro studies. (i) Bacterial adhesion assay. Streptococcus mutans MT8148 (serotype c), Streptococcus sanguis (serotype H), Actinomyces viscosus TPR-12, and Porphyromonas gingivalis were obtained from the Japanese Collection of Microorganisms of the Riken Bioresource Center (Tsukuba, Japan). Stock cultures were stored in 50% glycerol at –80°C. Inoculum from stock culture was grown anaerobically in brain heart infusion broth (Nippon Becton Dickinson Company, Ltd., Tokyo, Japan) for S. mutans and S. sanguis, in tryptic soy (TS) broth (Nippon Becton Dickinson Company, Ltd., Tokyo, Japan) for A. viscosus, or in TS broth supplemented with 5 mg of hemin/ml and 0.5 mg of menadione/ml for P. gingivalis in a model ANX-1W anaerobic box (Hirasawa Works, Inc., Tokyo, Japan) filled with 80% N2, 10% H2, and 10% CO2 at 37°C. For adhesion studies, the organisms were radiolabeled by growth at 37°C in brain heart infusion broth supplemented with 0.2% sucrose (for S. mutans and S. sanguis), TS broth (for A. viscosus), or TS broth supplemented with 5 µg of hemin/ml and 0.5 µg of menadione/ml and methyl[3H]thymidine (10 µCi/ml; Amersham Biosciences Corp., Tokyo, Japan) for 16 h in anaerobic conditions. Early-stationary-phase cells were washed three times with buffered KCl (0.05 M KCl, 1 mM CaCl2, 1 mM potassium phosphate, 0.1 mM MgCl2 [pH 6.0]) by centrifugation. The bacterial pellet was dispersed into buffered KCl containing 5 mg of bovine serum albumin/ml at approximately 109 CFU per ml (optical density at 600 nm of 0.2) by forced passage through a needle (25 gauge by 1 in.; Terumo, Japan) (15).
Bacterial adhesion onto HA was measured in vitro according to the method of Kishimoto et al. (15) with minor modifications. Sintered HA plates (sHA; 10 by 10 by 1 mm, Ca/P = 1.57; Olympus, Japan) (27) were equilibrated in buffered KCl at room temperature overnight. The plates were then treated in triplicate with 1 ml of dW or test polymer solution for 1 h at room temperature. After being washed with 2 ml of buffered KCl, the plates were treated with 500 µl of buffered KCl (for saliva-untreated HA plates) or saliva overnight at 4°C. The plates were washed twice with buffered KCl, followed by the addition of 1 ml of buffered KCl containing BSA (5 mg/ml) to block any uncoated regions of sHA (7), and then incubated at 37°C for 1 h with 1 ml of radiolabeled bacteria in buffered KCl containing albumin (5 mg/ml). The plates were washed three times with buffered KCl, and the number of bacteria attached to the plates was determined by direct scintillation counting using a liquid scintillation counter (2550 TR/LL; Packard, Tokyo, Japan). We counted background scintillation by using untreated HA plates in each experiment. The background was subtracted from each scintillation measurement to obtain the radioactivity of attached bacteria. We also counted the specific radioactivity of labeled bacteria (dpm per 109 CFU). The number of attached bacteria (CFUs) was calculated by dividing the radioactivity of attached bacteria by the specific radioactivity of labeled bacteria.
(ii) Labeling of salivary proteins. Salivary glycoproteins were radiolabeled by reductive methylation according to the method of Jentoft and Dearborn (14). One milligram of protein from parotid salivary secretion was incubated in a 1-ml reaction volume containing 4 mM [14C]formaldehyde (NEC-039H; Perkin-Elmer Japan Co., Ltd., Yokohama, Japan), 25 mM NaCNBH3, and 100 mM potassium phosphate buffer (pH 7.0). After incubation at 22°C for 95 min, 3 ml of 10% trichloroacetic acid was added. The precipitated protein was isolated by centrifugation, dissolved in buffered KCl, and dialyzed against buffered KCl (molecular cutoff, 10,000), and the protein concentration and radioactivity were measured with a liquid scintillation counter (2550 TR/LL; Packard).
(iii) Contact angle measurements. The hydrophobicities of the polymer coatings and the conditioned surfaces of HA plates were determined by the measurement of water contact angles formed by droplets with the volume of 1 µl using a CA-D contact angle meter (Kyowa Interface Science Co., Ltd., Saitama, Japan). Values for contact angles are the means of 5 drops on two surfaces.
In vivo studies. (i) Dental biofilm development in rats. Two-month-old male dental biofilm-susceptible ODU rats (13) were obtained from Kiyoshi Ohura (Osaka Dental University). We housed each two rats in a plastic cage in a room maintained at 23 ± 2.0°C, with a relative humidity at 55 x 10% and a daily photoperiod of 12 h. Rats had free access to a standard diet for the maintenance of rats (CE-2; CLEA Japan, Inc., Tokyo, Japan) and drinking water. All animal experiments were conducted in the Experimental Animal Facility of Kao Tochigi Institute. The Animal Care Committee of Kao Tochigi Institute approved the present study. All experiments strictly followed the guidelines of that committee. The handling of animals was monitored by officially qualified animal care personnel.
Rats were anesthetized with an intraperitoneal injection of Nembutal (25 mg/kg). Dental biofilm on the surface of lower incisors was disclosed prior to its removal by using a sterile scaler and cotton balls. The remaining interdental biofilm was removed by using dental floss. Complete plaque removal was confirmed by further disclosing.
Twenty rats were randomly divided into two groups. Control and experimental groups had free access to dW and the test solution, respectively. Both groups were fed on a powdered MF diet (Oriental Yeast Co., Ltd., Tokyo, Japan) containing 50% sucrose for 96 h. Both longitudinal and transverse distances of the disclosed area were measured on the buccal surface of each incisor by using a calibrated periodontal probe, to the nearest 0.5 mm (Thin Williams, Hu-Friedy, Chicago, IL). The area (in square millimeters) of dental biofilm deposition was calculated by multiplying the above measurement.
Each rat served as its own control, using a crossover experimental design in which half of the animals received test solution first and half received vehicle (dW) first. The drinking solution was replaced by the alternate treatment 5 days after the previous treatment had ceased.
(ii) Dental plaque development in humans. Systemically healthy adult subjects from Kao Tochigi Institute participated. No subjects exhibited clinical evidence of salivary gland disorder. Prior to the experiment, all subjects gave informed consent to the protocol, which was approved by the Ethics Committee of Kao Tochigi Institute.
Ten male subjects (26 to 40 years old) were randomly assigned to control (four subjects), pyrophosphate (PP; three subjects), or PP+polymer (three subjects) groups. Tooth biofilm was removed mechanically by a single well-trained oral hygienist. Dental plaque was disclosed prior to its removal by using rubber cups with polishing paste. The remaining interdental biofilm was removed with dental floss and polishing via Eva chips with polishing paste. Complete biofilm removal was confirmed by further disclosing.
Immediately after teeth cleaning, the subjects were requested to rinse their teeth with 20 ml of dW (for control subjects) or PP or PP+polymer solution. The subjects were instructed to rinse their teeth with the supplied solution before sleep. They were requested not to clean their teeth and not to consume alcohol and high sugar-containing products (e.g., sweets or sweet beverages) during the 24-h test period.
Dental biofilm accumulation was measured 24 h after teeth cleaning according to our previous study (29). Briefly, a single well-trained oral hygienist disclosed and measured the dental plaque on all buccal and lingual surfaces according to the method of Suzuki et al. (31). The distance from the gingival margin to the edge of the disclosed area was measured to the nearest 0.5 mm at five sections on either the buccal or lingual surfaces of each tooth by using a calibrated periodontal probe. Plaque-free sections were designated as "0 mm." A filled section of restored teeth was excluded from the measurement. To produce an unbiased estimate, the measurements on each tooth were averaged, and then the whole-mouth average distance (in millimeters) was calculated as the dental biofilm development.
The study had a single-blinded, crossover design. The mouth rinse solution was replaced by separate treatment at least 5 days after the previous treatment had ceased.
Statistical analysis. For the in vitro bacterial adhesion study, Student t tests after a preliminary F test of the homogeneity of within-group variance were used when we compared values between the parametric data. When more than two groups were compared, statistical analysis was conducted by using analysis of variance (ANOVA) and subsequently using Fisher PLSD multiple comparison (STATVIEW for Windows, version 5.0; SAS Institute, Inc., Cary, NC). For in vivo studies on dental biofilm formation, we adopted the Wilcoxon matched-pair signed-rank test for comparisons between nonparametric data. Numerical data were expressed as means ± the standard error of the mean (SEM). Differences were considered significant when the error probability was smaller than 0.05.
|
|
|---|
Substitution of MDP (polymers B and C) by MEP (polymer D) completely diminished the inhibitory effect of phosphorylated PEG on saliva-promoted S. mutans adhesion (Table 1, experiment 2). The inhibitory effect of phosphorylated PEG on S. mutans adherence onto saliva-treated HA surfaces decreased significantly when PEG was changed from120 EO (ethoxy group) (polymers E, H, I, and K) to either 90 (F and G) or 23 EO (J and L) (Table 1, experiments 3 and 4). Elimination of the methacrylate group did not affect the inhibitory effect of phosphorylated PEG.
Effect of MDP-PEG on adhesion of oral bacteria. The effect of MDP-PEG on the adhesion of other oral bacteria onto HA surfaces was examined. Adhesion of either S. sanguis (Fig. 2A), A. viscosus (Fig. 2B), or P. gingivalis (Fig. 2C) was promoted by the treatment of HA surfaces with parotid saliva. Pretreatment of HA plates with MDP-PEG, followed by saliva treatment, significantly reduced the adsorption of each bacterial type.
![]() View larger version (14K): [in a new window] |
FIG. 2. Inhibitory effect of MDP-PEG (10 mg/ml, l/m/n = 32/8/60, r = 10, q = 120, average MW = 35,000) on S. sanguis (A), A. viscosus (B), and P. gingivalis (C) adhesion onto sintered HA plates (means ± the SEM; n = 3). Statistical analysis was conducted by using ANOVA and then Fisher PLSD multiple comparison. Means not sharing a given letter (a, b, and c) differ significantly (P < 0.05).
|
|
View this table: [in a new window] |
TABLE 2. Water contact angles of polymer-treated HA surfaces
|
![]() View larger version (17K): [in a new window] |
FIG. 3. Inhibition of salivary protein adsorption onto sHA by polymer. Sintered HA plates (7 by 5 by 1 mm) were treated with MDP-PEG (l/m/n = 50/10/40, r = 10, q = 120, average MW = 34,000), followed by 14C-labeled salivary protein. After being washing, the plates were treated with 3H-labeled S. mutans. 14C-labeled protein adsorption (µg/cm2) (A) and 3H-labeled S. mutans adhesion (CFU/cm2) (B) onto the sHA surfaces were determined by direct scintillation counting (means ± the SEM; n = 3). Means not sharing a given letter (a, b, and c) differ significantly (P < 0.05).
|
![]() View larger version (59K): [in a new window] |
FIG. 4. Inhibitory effect of MDP-PEG (polymer A, Table 1) on dental biofilm formation in ODU rats at 96 h after feeding a high-sucrose powder diet. (A) Data represent the mean and standard error of 20 incisors (10 rats). A Wilcoxon matched-pair signed-rank test was conducted between dW (control) and polymer treatments. (B) Dental biofilm deposition on lower incisors of ODU rats administered dW (left) and MDP-PEG (10 mg/ml) (right) via drinking water.
|
![]() View larger version (11K): [in a new window] |
FIG. 5. Inhibitory effect of PP on S. mutans adhesion onto saliva-pretreated HA plates. Sintered HA plates were treated with parotid saliva followed by PP solution (0 to 30 mM). Three plates were treated further with parotid saliva after 30 mM PP treatment. After being washed, the plates were treated with 3H-labeled S. mutans. 3H-labeled S. mutans adhesion (CFU) onto the sHA surface was determined by direct scintillation counting (means ± the SEM; n = 3). Statistical analysis was conducted by using ANOVA and then a Fisher PLSD multiple comparison. Means not sharing a given letter (a, b, c, d, e, and f) differ significantly (P < 0.05).
|
![]() View larger version (12K): [in a new window] |
FIG. 6. Inhibition of S. mutans adhesion onto saliva-pretreated HA plates by MDP-PEG plus PP treatment. Sintered HA plates were treated with parotid saliva followed by PP (30 mM) or PP plus MDP-PEG (polymer E, Table 1, 10 to 50 mg/ml) solution. The plates were treated further with parotid saliva. After washing, the plates were treated with 3H-labeled S. mutans. 3H-labeled S. mutans adhesion (CFU) onto the sHA surface was determined by direct scintillation counting (means ± the SEM; n = 3). Statistical analysis was conducted by using ANOVA and then Fisher PLSD multiple comparison. Means not sharing a given letter (a, b, c, and d) differ significantly (P < 0.05).
|
![]() View larger version (67K): [in a new window] |
FIG. 7. Inhibitory effect of MDP-PEG plus PP on dental biofilm formation in humans. (A) Inhibitory effect of MDP-PEG (polymer E, Table 1) plus PP on dental biofilm formation in humans. The black dots indicate the dental biofilm deposition of each subject. The gray bars show the mean and standard error of 10 subjects. A Wilcoxon matched-pair signed-rank test was conducted between the groups. (B) Dental biofilm deposition in humans at 24 h after professional teeth cleaning, followed by dW (left) or MDP-PEG plus PP (right) mouth rinse.
|
|
|
|---|
It is well-known that phosphorylated biomolecules interact strongly with HA surfaces (10, 11). It has been suggested that statherin and histatin 1 bind quickly via their negatively charged N-terminal domains onto HA surfaces (5, 26) and compete with larger salivary glycoproteins for a similar binding site upon HA surfaces (8, 28). Our protein adsorption study clearly shows that 14C-labeled salivary protein adsorption is inhibited by pretreatment of the HA surface with MDP-PEG. This compound probably competes favorably with ionic groups, e.g., carboxyl groups, of S. mutans-binding salivary proteins for calcium ions on the HA surface. MDP-PEG reduced the HA attachment of not only S. mutans but also A. viscosus and P. gingivalis, of which adhesion was strongly promoted by salivary acidic proline-rich proteins (6). Thus, the inhibitory effect of MDP-PEG on the adhesion of these bacteria might be attributed to the reduced adsorption of salivary components, e.g., acidic proline-rich proteins that promote bacterial binding. Substitution of MDP (polymers B and C) by MEP (polymer D) completely diminished the hydrophilizing effect of MDP-PEG on the HA surface, as well as its inhibitory effect on saliva-promoted S. mutans adhesion. This implies that the alkyl spacer separating the phosphate group from the polymer chain may be critical for hydrophilization of the HA surface by this compound and thereby the prevention of salivary protein adsorption onto HA surfaces.
MDP-PEG, a novel antiadherent polymer, prevents biofilm development on lower incisors in ODU rats when applied immediately after teeth cleaning and then via drinking water. MDP-PEG did not show bactericidal activities in our preliminary study (data not shown), suggesting that the anti-dental biofilm activities of this compound in vivo are attributed to reduced initial bacterial attachment onto enamel surfaces.
In the human oral environment, the tooth surface is covered by salivary secretion immediately after teeth cleaning. When MDP-PEG was added to saliva-pretreated HA surfaces, its inhibitory effect on bacterial binding was completely diminished. This is consistent with the study of Olsson et al. (19), who showed that triphosphate of polyalkylene oxide glycerol did not reduce S. mutans adherence to saliva-coated HA surfaces, probably because the binding of this compound was effectively prevented by salivary components already bound to the HA. Thus, desorption of salivary components from the HA surface seemed essential for the antiadherence strategy using MDP-PEG in the human oral environment.
PP treatment of saliva-pretreated HA reduced S. mutans adherence successfully to the saliva-untreated HA level at a concentration of 30 mM. This is compatible with earlier studies which showed PP desorbed protein and acquired pellicles from HA surfaces (24, 25). However, reduced bacterial binding onto saliva-pretreated HA by PP was overshadowed by additional treatment of the HA surface with saliva. This may be due to the readsorption of salivary proteins on HA surfaces. Therefore, we combined PP and MDP-PEG to accomplish either the desorption of salivary components from HA surfaces or the prevention of protein and bacterial attachment onto HA surfaces. Treatment of saliva-pretreated HA surfaces with MDP-PEG plus PP could reduce S. mutans adhesion even when followed by additional saliva treatment. However, the inhibitory effect of MDP-PEG (10 mg/ml) on bacterial adhesion was greatly diminished by the addition of PP (30 mM), conceivably because PP may interfere with MDP-PEG adsorption onto HA surfaces. When combined with PP, a higher concentration (50 mg/ml) of MDP-PEG is necessary for the complete inhibition of saliva-promoted bacterial adherence.
In our clinical study, mouthwash with PP alone prevented de novo biofilm development after thorough teeth cleaning in humans, presumably because PP desorbs acquired pellicles and retards pellicle formation. It should be noted that MDP-PEG plus PP reduced biofilm formation more than PP alone. The additional prevention of biofilm development by MDP-PEG plus PP may be attributed to the prevention of protein and bacterial attachment onto the HA surface by MDP-PEG.
We previously found that de novo dental biofilm development in vivo was positively correlated with saliva-promoted S. mutans adhesion onto HA surface in vitro (29). This finding encouraged us to study whether dental biofilm formation could be reduced by an antiadherence strategy. Reduction of de novo dental biofilm development by MDP-PEG plus PP was consistent with our previous finding (29). Dental biofilm formation could likely be controlled by antiadherence MDP-PEG plus PP treatment. The results of this pilot study, while encouraging, should be considered preliminary and not conclusive. Further study using a larger number of human subjects is necessary to corroborate this preliminary finding.
Finally, we conclude MDP-PEG plus PP has the potential for use as an antiadherence agent in mouthwash and prevents dental biofilm formation after thorough teeth cleaning. The use of antimicrobial agents is probably the most common approach for oral hygiene in developed nations. An alternative approach is to prevent the initial attachment of bacteria to the tooth surface. Although the above antiadherence agents are effective, total reduction of dental biofilm deposition is unlikely. Dental biofilm should be preferably controlled accompanied by a skewed repopulation of the innocuous members of the commensal flora. Thus, further studies are still required to control dental biofilm, e.g., by directing a combined antiadherence/antimicrobial strategy at specific pathogenic threats.
Published ahead of print on 23 July 2007. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»